Annual income statement for GMO Pepabo, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | — | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11,880 | 10,531 | 10,904 | 10,923 | 10,959 |
| Cost of Revenue | |||||
| Gross Profit | 6,733 | 6,076 | 5,931 | 5,779 | 5,964 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10,991 | 9,795 | 11,394 | 10,094 | 10,026 |
| Operating Profit | 889 | 737 | -490 | 829 | 933 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,065 | 771 | -396 | 937 | 1,264 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 715 | 487 | -629 | 592 | 878 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 715 | 510 | -629 | 592 | 878 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 715 | 510 | -629 | 592 | 878 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 122 | 95.9 | -101 | 112 | 164 |
| Dividends per Share | |||||
| Special Dividends per Share |